Vicks Action 500 Extra sale stopped in India by P&G after ban

The US consumer health giant Procter & Gamble has stopped the manufacture and sale of its cough-and-cold medicine Vicks Action 500 Extra.

Last Updated: Mar 15, 2016, 10:33 AM IST
Photo credit: P&G website

Zee Media Bureau

New Delhi: With the Indian Health Ministry banning around 350 fixed dose combination (FDC) drugs in the nation over safety concerns.

Recently, the US consumer health giant Procter & Gamble has stopped the manufacture and sale of its cough-and-cold medicine Vicks Action 500 Extra immediately.

This move was executed after regulators banned it citing potential health risk.

The drug was one of 344 drug combinations including several antibiotics and analgesics that India ordered to be prohibited saying a government-appointed panel of experts had found that the combinations lacked "therapeutic justification."

P&G said all its products, including Vicks Action 500 Extra, were backed by research to support their quality, safety and efficacy.

It wasn't immediately clear how much the product contributed to P&G's sales.

(With Agency Inputs)